ENGNenGene Therapeutics Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Last close $2.00 · 2026-09-30

ABOUT

ExchangeNASDAQ

SectorHealthcare

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Market cap$133.98M

CountryUSA

RECENT INSIDER TRADES

INSTITUTIONAL OWNERSHIP

Institutional holders56

Shares held38,491,618

Value$66.47M

Percent of shares outstanding57.46%

As of quarter end2026-06-30